Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

NCT01198665 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01198665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01198665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas
Lead sponsor
Samsung Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2010
Completion date
December 31, 2014
Enrollment
46 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic large cell lymphoma, alk-negative, angioimmunoblastic t cell lymphoma, cutaneous t cell lymphoma, peripheral t cell lymphoma unspecified